1. Home
  2. XENE vs FL Comparison

XENE vs FL Comparison

Compare XENE & FL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • FL
  • Stock Information
  • Founded
  • XENE 1996
  • FL 1879
  • Country
  • XENE Canada
  • FL United States
  • Employees
  • XENE N/A
  • FL N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • FL Clothing/Shoe/Accessory Stores
  • Sector
  • XENE Health Care
  • FL Consumer Discretionary
  • Exchange
  • XENE Nasdaq
  • FL Nasdaq
  • Market Cap
  • XENE 2.3B
  • FL 2.3B
  • IPO Year
  • XENE 2014
  • FL N/A
  • Fundamental
  • Price
  • XENE $32.05
  • FL $23.98
  • Analyst Decision
  • XENE Strong Buy
  • FL Hold
  • Analyst Count
  • XENE 11
  • FL 15
  • Target Price
  • XENE $54.82
  • FL $21.00
  • AVG Volume (30 Days)
  • XENE 977.8K
  • FL 3.8M
  • Earning Date
  • XENE 08-07-2025
  • FL 05-29-2025
  • Dividend Yield
  • XENE N/A
  • FL N/A
  • EPS Growth
  • XENE N/A
  • FL N/A
  • EPS
  • XENE N/A
  • FL N/A
  • Revenue
  • XENE $7,500,000.00
  • FL $7,903,000,000.00
  • Revenue This Year
  • XENE N/A
  • FL $1.29
  • Revenue Next Year
  • XENE $253.71
  • FL $2.31
  • P/E Ratio
  • XENE N/A
  • FL N/A
  • Revenue Growth
  • XENE N/A
  • FL N/A
  • 52 Week Low
  • XENE $26.74
  • FL $11.00
  • 52 Week High
  • XENE $46.00
  • FL $33.94
  • Technical
  • Relative Strength Index (RSI)
  • XENE 51.34
  • FL 74.97
  • Support Level
  • XENE $31.22
  • FL $23.90
  • Resistance Level
  • XENE $33.46
  • FL $24.19
  • Average True Range (ATR)
  • XENE 1.28
  • FL 0.16
  • MACD
  • XENE 0.27
  • FL -0.39
  • Stochastic Oscillator
  • XENE 68.60
  • FL 46.87

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About FL Foot Locker Inc.

Foot Locker Inc operates footwear and apparel retailer in North America, Europe, Australia, New Zealand, and Asia, and has licensed store presence in the Middle East, Europe, and Asia. The company mainly sells athletically inspired shoes and apparel. Foot Locker's merchandise comes from only a few suppliers, with Nike providing the majority. Its portfolio of brands includes Foot Locker, Kids Foot Locker, Champs Sports, WSS, and atmos. The company has omnichannel capabilities to bridge the digital world and physical stores, including order-in-store, buy online and pickup-in-store, and buy online and ship-from-store, as well as e-commerce. It has three operating segments, North America, EMEA, and Asia Pacific.

Share on Social Networks: